Semtech acquires HieFo Corporation for $34M, adding InP technology to its AI data center portfolio. Read about this major ...
Mediated Microenvironmental Modulation Targeting Osteoclasts for ONFH Niche Reprogramming" has been published in ...
EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, releases today the ...
Scientists in Switzerland collected and compared blood samples from healthy younger individuals aged 30 to 60, hospitalized octogenarians aged 80 to 90, and centenarians aged 100 years and older, ...
Chronic diabetic ulcers represent one of the most challenging complications in modern healthcare, affecting over 131 million people worldwide and generating approximately $755 billion in annual ...
A team of researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital reports in Science Translational Medicine a potential new ...
Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, today announced that LoRa® ...
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...
A research team led by Professors Caichao Wan and Yiqiang Wu at Central South University of Forestry and Technology reports on synergistic strategies that combine ultramicropore confinement with ...
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease ...
A team of researchers at Texas Children's Duncan Neurological Research Institute (NRI) and Baylor College of Medicine report ...
Thymagen has emerged as a notable compound in contemporary peptide science due to its structural relationship to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results